China is the world’s second-largest beauty and personal care market, with retail sales exceeding $65 billion in 2025 and double-digit growth continuing in premium skincare, haircare, and cosmeceuticals. For foreign brands, the opportunity is real — but the regulatory pathway is among the most demanding of any consumer product category. China’s National Medical Products Administration (NMPA) governs the sector with strict pre-market approval requirements, mandatory animal testing exemptions that are narrower than many brands expect, and labeling rules that differ significantly from US or EU standards.
This guide walks through the current regulatory framework, the approval process, and what brands need to know before committing resources to the Chinese market.
The Governing Framework: NMPA and the 2021 Cosmetics Supervision and Administration Regulation
China’s cosmetics regulatory landscape was substantially overhauled in January 2021, when the Cosmetics Supervision and Administration Regulation (化妆品监督管理条例, CSAR) came into full effect, replacing the 1989 Hygiene Supervision Regulations. The CSAR introduced a tiered classification system, elevated safety obligations for “responsible persons,” and tightened labeling requirements. Supporting administrative measures — including the Measures for the Administration of Cosmetics Registration and Filing — took effect in 2022 and 2023.
All cosmetics sold in China are regulated by the NMPA (formerly CFDA). Products are split into two tiers:
- Special Cosmetics (特殊化妆品): Products with claims related to hair coloring, perming, hair loss prevention, freckle lightening/whitening, anti-wrinkle, sun protection, or products intended for children under 12. These require formal registration (注册, zùcè) with the NMPA before sale.
- General Cosmetics (普通化妆品): All other personal care products — moisturizers, shampoos, foundations, lipsticks, etc. These require only filing (备案, bèi’àn), a lighter-touch notification process.
The practical implication: a basic moisturizer with no whitening or anti-aging claims can reach market faster than a vitamin C serum positioned as brightening. Understand how your product will be classified before you formulate your market strategy.
The Responsible Person Requirement
A key feature of China’s cosmetics rules is the Responsible Person (责任人) requirement. Every cosmetic product sold in China must have a designated responsible person — either the brand’s China-registered entity or a licensed third-party agent based in China. This person (or entity) is legally accountable for product safety, recall compliance, and consumer complaint handling.
For foreign brands without a China entity, this means working with a licensed import agent who assumes legal liability. This is common practice but carries risk: if the agent’s licenses lapse or the relationship deteriorates, your products can be pulled from shelves. Brands doing serious volume in China typically establish a Wholly Foreign-Owned Enterprise (WFOE) to serve as their own responsible person — giving them direct control over compliance.
Registration vs. Filing: What Each Process Involves
Special Cosmetics Registration
The NMPA registration process for special cosmetics is thorough and slow. Expect 6 to 18 months from application to approval, and budget accordingly. Key requirements include:
- Complete formula disclosure (all ingredients, concentrations, trade names, and INCI names)
- Safety assessment report prepared by a qualified assessor
- Efficacy testing documentation for the specific claim being made
- China-specific stability and microbial challenge test reports
- Product labeling draft for NMPA review
- Manufacturing site information, including GMP certificates from the country of origin
All documentation must be submitted in Mandarin or accompanied by certified translations. The NMPA has an online portal — the Cosmetics Intelligent Regulatory System (CIRS) — through which applications are submitted and tracked.
General Cosmetics Filing
For non-special cosmetics, the filing process is lighter but not trivial. Since 2022, cross-border e-commerce (CBEC) channels allow a simplified filing path, enabling brands to begin test-selling on platforms like Tmall Global or JD International before completing full in-market registration. This is a useful pilot strategy for brands testing demand without committing to full market entry.
However, CBEC filing does not allow products to be sold in physical retail, and products cannot be re-labeled or re-packaged in China. Brands planning brick-and-mortar distribution or any form of domestic resale must complete the standard general filing with NMPA through their responsible person.
Animal Testing: The Current Reality
China’s animal testing requirements have been one of the most discussed barriers for foreign beauty brands, particularly cruelty-free and vegan-positioned products. The rules have evolved significantly since 2021:
- Domestically manufactured general cosmetics: Animal testing has been eliminated since 2021.
- Imported general cosmetics (non-special): Animal testing is no longer mandatory at the national level since May 2021, provided the brand can submit a safety assessment report and a Good Manufacturing Practice (GMP) certificate from a recognized overseas authority.
- Special cosmetics (imported or domestic): Animal testing requirements remain in place for certain efficacy claims that lack validated alternative methods under Chinese regulatory standards.
In practice, the exemption for imported general cosmetics is real but conditional. The safety assessment must follow NMPA’s specific methodology, and not all third-party labs are recognized. Work with a regulatory consultant experienced in NMPA submissions to ensure your safety dossier meets current standards. The exemption also does not apply to functional claims — a moisturizer marketed without anti-aging or brightening language may avoid testing; the same product positioned as a cosmeceutical likely will not.
Labeling Requirements: What Must Appear on Every Product
China’s labeling requirements under the CSAR and the Measures for the Administration of Cosmetics Labeling (2022) are specific. Every product sold in China must display:
- Full ingredient list (INCI names in Chinese or pinyin, listed in descending order of concentration)
- Net content in metric units
- Manufacturing date and shelf life (or period after opening, PAO)
- Name and address of the responsible person in China
- Country of origin
- NMPA registration or filing number
- Batch/lot number
- Any required safety warnings
Chinese language labeling is mandatory for all physical retail products. The label cannot simply translate your existing packaging — several elements require China-specific data (filing number, responsible person address) that only exist after regulatory clearance is obtained. Budget for label re-design and plan for lead time before manufacturing the first China-bound shipment.
One common pitfall: claims that are acceptable in the US or EU may constitute “special cosmetics” claims in China, triggering the full registration pathway. Phrases like “reduces wrinkles,” “brightens skin tone,” or “strengthens hair” need to be carefully reviewed by a China regulatory specialist before being used on packaging or marketing materials.
Distribution Channels and Their Regulatory Implications
How you plan to sell determines what regulatory pathway applies:
- Cross-Border E-Commerce (CBEC): Simplified filing path; suitable for market testing. Products ship from bonded warehouses or directly from overseas. Cannot be sold offline or re-sold domestically.
- General Trade (Import): Standard filing or registration required. Allows physical retail, wholesale, and sub-distribution. Products must clear customs with full NMPA approval in place.
- Domestic Manufacturing: Brands can partner with a licensed Chinese contract manufacturer. Product is classified as domestically produced, which reduces some testing requirements but requires the manufacturer to hold the relevant NMPA production license and quality certifications.
For most foreign brands entering China for the first time, CBEC via Tmall Global or JD International is the lowest-friction starting point. It provides real sales data before committing to the full in-market registration process.
Timing and Cost Benchmarks
Foreign brands frequently underestimate the cost and timeline of China cosmetics compliance. Realistic benchmarks as of 2026:
- General cosmetics filing: 3 to 6 months; regulatory consulting fees typically $2,000 to $5,000 per SKU depending on complexity
- Special cosmetics registration: 12 to 18 months; $8,000 to $20,000+ per SKU, including required testing
- Safety assessment: $1,500 to $4,000 per product; required for both tracks
- Animal testing (where still required): 4 to 6 months; $3,000 to $7,000 per product at an NMPA-recognized testing facility
A 10-SKU launch with a mix of general and special cosmetics products can easily require $150,000 to $250,000 in regulatory spend before the first sale. Brands must weigh this investment against projected revenue and competitive dynamics in the category. For products that need to be adapted for Chinese consumer preferences, additional localization costs apply.
Children’s Cosmetics: The Strictest Category
The NMPA introduced the Technical Specifications for Children’s Cosmetics in 2021, creating some of the strictest rules in the world for products marketed to children under 12. Requirements include:
- Mandatory “Children Cosmetics” logo (小金盾) on all compliant products
- Restricted ingredient list — many actives permitted in adult products are prohibited
- No special cosmetics claims permitted for children’s products
- Enhanced safety assessment and testing requirements
Any brand in the baby care or children’s skincare space must comply fully with these specifications. The children’s cosmetics category is heavily inspected, and non-compliance has resulted in high-profile recalls of foreign brands in China.
Preparing Your Entry Strategy
China’s beauty market rewards brands that treat regulatory compliance as a strategic asset rather than a checkbox exercise. Brands that enter with full NMPA approval, China-optimized labeling, and a clear responsible person structure are positioned to scale quickly once demand is validated. Brands that cut corners — relying on gray-market daigou channels or unauthorized resellers — face enforcement risk and brand reputation damage that can be difficult to recover from.
The most effective entry approach combines CBEC for early market testing with parallel NMPA registration for the core SKU range, targeting general trade distribution within 18 to 24 months of initial launch. This phased approach limits upfront regulatory spend while building the compliance infrastructure needed for sustainable growth.
For additional guidance on building distribution and brand presence in China, the US-China Business Council maintains updated industry briefings on regulatory developments, and the US Commercial Service China desk provides market intelligence and matchmaking support for American exporters. For strategic positioning and market entry structure decisions, legal counsel familiar with both NMPA regulations and China’s Foreign Investment Law will be essential.